Jingjing Wang

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Bispecific c-Met/PD-L1 CAR-T Cells Have Enhanced Therapeutic Effects on Hepatocellular Carcinoma

Wei Jiang, Tao Li, Jiaojiao Guo et al. · Frontiers in Oncology · 2021 · 82 citations · Full text

Life Sciences, Immunology, Oncology +17

Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib for Patients With Unresectable or Metastatic Hepatocellular Carcinoma

Xin Zhang, Jingjing Wang, Juanjuan Shi et al. · JAMA Network Open · 2021 · 79 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

Prognostic Nutritional Index identifies risk of early progression and survival outcomes in Advanced Non-small Cell Lung Cancer patients treated with PD-1 inhibitors

Na Liu, Aimin Jiang, Xiaoqiang Zheng et al. · Journal of Cancer · 2021 · 68 citations · Full text

Medicine, Nutrition, Oncology +17

Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension

Jian Xu, Jingjing Wang, Mengyu He et al. · Laboratory Investigation · 2018 · 56 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8